Wang A, Walden M, Ettlinger R, Kiessling F, Gassensmith J, Lammers T
Adv Funct Mater. 2024; 34(43).
PMID: 39726715
PMC: 7617264.
DOI: 10.1002/adfm.202308589.
Shaykhutdinov I, Iliasov P, Limareva L, Sustretov A, Kokorev D, Sokolov A
Sovrem Tekhnologii Med. 2024; 16(1):5-13.
PMID: 39421628
PMC: 11482095.
DOI: 10.17691/stm2024.16.1.01.
Ma Y, Liao J, Cheng H, Yang Q, Yang H
Mater Today Bio. 2024; 27:101138.
PMID: 39027677
PMC: 11255123.
DOI: 10.1016/j.mtbio.2024.101138.
Zhu K, Wang L, Xiao Y, Zhang X, You G, Chen Y
J Nanobiotechnology. 2024; 22(1):336.
PMID: 38880905
PMC: 11180412.
DOI: 10.1186/s12951-024-02606-1.
Yu P, Zheng X, Alimi L, Al-Babili S, Khashab N
ACS Appl Mater Interfaces. 2024; 16(15):18245-18251.
PMID: 38564422
PMC: 11040530.
DOI: 10.1021/acsami.3c19571.
Recent Progress and Prospect of Metal-Organic Framework-Based Nanozymes in Biomedical Application.
Baranwal A, Polash S, Kumar Aralappanavar V, Behera B, Bansal V, Shukla R
Nanomaterials (Basel). 2024; 14(3).
PMID: 38334515
PMC: 10856890.
DOI: 10.3390/nano14030244.
Synthesis and evaluation of gene delivery vectors based on PEI-modified metal-organic framework (MOF) nanoparticles.
Khosrojerdi S, Gholami L, Khazaei M, Hashemzadeh A, Darroudi M, Kazemi Oskuee R
Iran J Basic Med Sci. 2024; 27(2):203-213.
PMID: 38234668
PMC: 10790290.
DOI: 10.22038/IJBMS.2023.71892.15644.
Synergistic glycolysis disturbance for cancer therapy by a MOF-based nanospoiler.
Zeng X, Ruan Y, Wang L, Deng J, Yan S
Biophys Rep. 2023; 9(3):134-145.
PMID: 38028149
PMC: 10648233.
DOI: 10.52601/bpr.2023.230003.
Editorial: Non-viral vectors for gene therapy/nucleic acid delivery.
Poddar A, Banerjee R, Shukla R
Front Bioeng Biotechnol. 2023; 11:1304769.
PMID: 38026859
PMC: 10644872.
DOI: 10.3389/fbioe.2023.1304769.
Constructing Physiological Defense Systems against Infectious Disease with Metal-Organic Frameworks: A Review.
Mishra N, Quon A, Nguyen A, Papazyan E, Hao Y, Liu Y
ACS Appl Bio Mater. 2023; 6(8):3052-3065.
PMID: 37560923
PMC: 10445270.
DOI: 10.1021/acsabm.3c00391.
Amino Acid-Coated Zeolitic Imidazolate Framework for Delivery of Genetic Material in Prostate Cancer Cell.
Polash S, Garlick-Trease K, Pyreddy S, Periasamy S, Bryant G, Shukla R
Molecules. 2023; 28(12).
PMID: 37375429
PMC: 10302622.
DOI: 10.3390/molecules28124875.
biocompatibility of ZIF-8 for slow release intranasal administration.
Kumari S, Howlett T, Ehrman R, Koirala S, Trashi O, Trashi I
Chem Sci. 2023; 14(21):5774-5782.
PMID: 37265713
PMC: 10231336.
DOI: 10.1039/d3sc00500c.
Combination therapy based on dual-target biomimetic nano-delivery system for overcoming cisplatin resistance in hepatocellular carcinoma.
Huang Y, Kou Q, Su Y, Lu L, Li X, Jiang H
J Nanobiotechnology. 2023; 21(1):89.
PMID: 36918874
PMC: 10015699.
DOI: 10.1186/s12951-023-01840-3.
ZIF-8@Rhodamine B as a Self-Reporting Material for Pollutant Extraction Applications.
Moore E, Maya F
Nanomaterials (Basel). 2023; 13(5).
PMID: 36903719
PMC: 10005746.
DOI: 10.3390/nano13050842.
A quest for cytocompatible metal organic frameworks in non-viral gene therapy: Relevance of zeolitic imidazolate framework-8.
Poddar A, Pyreddy S, Polash S, Doherty C, Shukla R
Biomater Biosyst. 2023; 8:100065.
PMID: 36824375
PMC: 9934432.
DOI: 10.1016/j.bbiosy.2022.100065.
Elettra-Sincrotrone Trieste: present and future.
Franciosi A, Kiskinova M
Eur Phys J Plus. 2023; 138(1):79.
PMID: 36712550
PMC: 9872737.
DOI: 10.1140/epjp/s13360-023-03654-6.
Targeted gene silencing of E2 and nsP1 genes of chikungunya virus by biocompatible zeolitic imidazolate framework.
Tagore R, Alagarasu K, Patil P, Pyreddy S, Polash S, Kakade M
Front Bioeng Biotechnol. 2023; 10:1003448.
PMID: 36601387
PMC: 9806579.
DOI: 10.3389/fbioe.2022.1003448.
Carrier gas triggered controlled biolistic delivery of DNA and protein therapeutics from metal-organic frameworks.
Wijesundara Y, Herbert F, Trashi O, Trashi I, Brohlin O, Kumari S
Chem Sci. 2022; 13(46):13803-13814.
PMID: 36544734
PMC: 9710232.
DOI: 10.1039/d2sc04982a.
Nanoparticles-mediated CRISPR-Cas9 gene therapy in inherited retinal diseases: applications, challenges, and emerging opportunities.
Chien Y, Hsiao Y, Chou S, Lin T, Yarmishyn A, Lai W
J Nanobiotechnology. 2022; 20(1):511.
PMID: 36463195
PMC: 9719668.
DOI: 10.1186/s12951-022-01717-x.
App-based quantification of crystal phases and amorphous content in ZIF biocomposites.
Hafner M, Villanova L, Carraro F
CrystEngComm. 2022; 24(41):7266-7271.
PMID: 36353391
PMC: 9595036.
DOI: 10.1039/d2ce00073c.